# Gilead Sciences, Inc. (GILD) — Q3-2009 Earnings Results

**Report date:** 2009-10-20 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q3-2009

## Post-Earnings Brief

### Headline

Gilead Sciences Beats on EPS, Stock Reaction N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.78 | N/A | +13.37% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding their future prospects. They emphasized the importance of their product pipeline.

**Key quotes:**

> Management highlighted the strong performance in their key therapeutic areas.

> They expressed confidence in their pipeline and ongoing research efforts.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Gilead Sciences reported a better-than-expected EPS, indicating strong performance in certain areas. However, the lack of revenue data and guidance leaves some uncertainty for investors. The stock reaction is not available, which may reflect the cautious sentiment in the market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q3-2009_